Answers are grounded in this paper and cite their sources.
Longitudinal analysis shows similar clinical progression in LRRK2-positive PD and sporadic PD, suggesting potential shared pathways.
Longitudinal clinical progression of S+ LRRK2-PD and sPD in the PPMI study is similar despite differences in baseline features.
No takes yet. Share an insight, caveat, or question.
Morse et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: